Tuesday, July 15, 2025
  • Home
  • About us
  • Privacy policy
  • Advertise with us
  • Contact us
Fii News Logo
No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Newsletter
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports
Fiinews
No Result
View All Result
Home Health

Kashiv Acquires global brand Adello Biologics

Fiinews by Fiinews
January 4, 2019
in Health, Industry Sectors, Investment
Reading Time: 1 min read
A A
0
0
SHARES
10
VIEWS
LinkedinShare on Twitter

0:00

Kashiv expands with BioSciences

 

Adello Biologics

 

 

Kashiv Pharma has acquired the assets of Adello Biologics, LLC, a biotechnology company developing biosimilars of leading global brands in the fields of oncology and immunology.

Kashiv will now be known as, LLC, with its headquarters in Bridgewater, New Jersey, plus research and development and manufacturing facilities in Bridgewater and Piscataway, New Jersey, Chicago, Illinois and Ahmedabad.

Established in 2010, Kashiv Pharma focuses on innovative drug delivery systems and specialty drug products for the treatment of various debilitating diseases.

The company seeks to partner with established pharmaceutical firms to commercialize products at an appropriate stage of development by offering novel products based on the next generation of advanced drug delivery platforms.

Kashiv has created several proprietary technology platforms under the leadership of Dr. Navnit Shah, a world-renowned pharmaceutical scientist, for extended and time-specific oral delivery of small molecules including a novel gastric retention system (GRANDE™) and a chronobiological delivery system (KRONOTEC™).

These advanced drug delivery systems target the drug to its optimal absorption site and at a time when the body needs it the most for maximal therapeutic effect.

Currently based in Piscataway and Chicago, Adello Biologics has been working to develop high-quality, affordable biosimilars for patients worldwide.

The company is advancing a pipeline of complex proteins and monoclonal antibodies with lead candidates in oncology and immunology. fiinews.com

Tags: Adello BiologicsKashiv PharmaLLC
ShareTweetShare

Related Posts

Jupiter Wagons
Investment

Invest: Jupiter commits Rs.3,000cr to rail projects

by Fiinews
July 15, 2025
0
15

Railway pioneering green corridor initiatives, says Gupta Private sector participation is accelerating technological advancements, with Jupiter Wagons Limited committing over...

IVCA
Investment

Invest: India requires $150-$200bn for renewables

by Fiinews
July 10, 2025
0
25

Mumbai to host Renewable Energy Summit 2025 India will require another US$150-US$200 billion investments for renewables over the next five...

Veeda Lifesciences Logo

Invest: Veeda to leverage Mango AI capabilities

July 9, 2025
13
IPA

Invest: Serendipity Space raises pre-seed round

July 5, 2025
17
Indian Steel Association

Invest: India needs $200bn for expansion of mills

July 4, 2025
19
PIB

Invest: PSBs told to strengthen credit to MSMEs

June 29, 2025
17
SBI YONO

POPULAR NEWS

  • Cristina Dnv

    Projects: Indian yards set to build green ships, says DNV expert

    0 shares
    Share 0 Tweet 0
  • Market: Indian-origin UGF scales heritage consumer brands globally

    0 shares
    Share 0 Tweet 0
  • Technologies: Royal Diamond sponsors aerspace Industries’ drones in UAE

    0 shares
    Share 0 Tweet 0
  • Investments: Foreign investors see India as long-term destination for fund placings

    0 shares
    Share 0 Tweet 0
  • Markets: Blue Dart maintains positive outlook on India

    0 shares
    Share 0 Tweet 0

Fiinews.com features through news articles on business opportunities in the Indian market for the benefits of foreigners. It is also a platform for international businesses to showcase through elaborate articles on their products & services to the Indian consumers and corporations exploiting industrialisation of the country.

7Clicks Media is a Singapore based Media & PR company offering over 100,000
impressions via our targeted communication strategy.

It is led by editor-in-chief Gurdip Singh who has worked over 45 years reporting on
Asian businesses.

Recent News

  • Tender: Minister officiates on Rs.2,000cr projects
  • Project: Update on Japanese-suppoted bullet train
  • Tender: Strategies needed for BIMSTEC ports
  • Export: ODOP international footprint expands
  • Export: Guidelines soon to put more ODOP on global markets

Pages

  • About US
  • ADVERTISE ON FIINEWS.COM
  • CONTACT US
  • EVENTS
  • FII-NEWS.COM PDF ARCHIVE
  • Home
  • News
  • PRIVACY POLICY

Subscribe to Newsletter

  • About
  • Advertise
  • Careers
  • Contact us

© 2024 FIINEWS - Design and developed by 7clicksmedia.

No Result
View All Result
  • Tenders
  • Projects
  • Markets
  • Manufacturing
  • Investment
  • Technology
  • Exports

© 2024 FIINEWS - Design and developed by 7clicksmedia.